ACEIs involve more dry cough than ARBs
An Agency for Healthcare Research & Quality comparison of two classes of antihypertensives has found that both work equally well at managing hypertension, but ACE inhibitors are linked to more dry cough than angiotensin receptor blockers.
A new Agency for Healthcare Research & Quality study has found that two classes of antihypertensivesangiotensinconverting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs)-are equally effective at managing hypertension. However, of the two, ACEIs are associated with a higher incidence of dry cough than ARBs (1.7% versus 0.6%). The study, done by AHRQ's Duke University Evidence-based Practice Center, covered 16,597 patients for 12 weeks to five years. It did not examine other blood pressure medications, such as diuretics or beta-blockers. The results can be accessed at AHRQ's Effective Health Care
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
